Supplementary Materials

The PDF file includes:

  • Materials and Methods
  • Fig. S1. Gating strategy for γδ T cells.
  • Fig. S2. Tree maps showing the TCRγ chain repertoire diversity of sequenced samples.
  • Fig. S3. Venn diagrams of all patients (n = 8) showing number of TCRγ chain clonotypes shared between the paired samples of each patient.
  • Fig. S4. Soluble factors in blood, ascites, and tumor tissue of patients with EOC and IL-17A secretion from short-term stimulation.
  • Fig. S5. Additional associations between clinical parameters, γδ T cell functionality, patient OS, and αβ T cell functionality.
  • Table S1. Clinical parameters of patients with EOC (n = 22).
  • Table S2. EOC patient samples and method usage overview.
  • Table S3. Antibodies, reagents, software/algorithms, and apparatus with manufacturer or source.
  • References (6165)

[Download PDF]

Other Supplementary Material for this manuscript includes the following:

  • Data file S1 (Microsoft Excel format). Top 10 clones in blood, ascites, and tumor.
  • Data file S2 (Microsoft Excel format). Top 10 TRGV9 clones in blood, ascites, and tumor.
  • Data file S3 (Microsoft Excel format). Clonotype differential abundance.
  • Data file S4 (Microsoft Excel format). Primary data.